Axillary lymphadenectomy for breast cancer and fibrin glue

Ann Ital Chir. 2014 Jan-Feb;85(1):88-92.

Abstract

Background: Axillary lymphadenectomy or sentinel biopsy is integral part of breast cancer treatment, yet seroma formation occurs in 15-85% of cases. Among methods employed to reduce seroma magnitude and duration, fibrin glue has been proposed in numerous studies with controversial results.

Methods: Eighty patients underwent quadrantectomy or mastectomy with level I/II axillary lymphadenectomy; a suction drain was fitted in all patients. Fibrin glue spray were applied to the axillary fossa in 40 patients; the other 40 patients were treated conventionally.

Results: Suction drainage was removed between post-operative Days 3 and 4. Seroma magnitude and duration were significantly reduced (p=0.004 and 0.02, respectively), and there were fewer evacuative punctures, in patients receiving fibrin glue compared with the conventional treatment group.

Conclusions: Use of fibrin glue does not always prevent seroma formation, but does reduce seroma magnitude, duration and necessary evacuative punctures.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / surgery*
  • Axilla
  • Breast Neoplasms / surgery*
  • Drainage
  • Female
  • Fibrin Tissue Adhesive / therapeutic use*
  • Humans
  • Lymph Node Excision*
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Seroma / prevention & control*

Substances

  • Fibrin Tissue Adhesive